Risk profiling patients for selective use of drug-eluting stents is warranted.
Farkouh
Michael E
ME
Mount Sinai Cardiovascular Institute, Mount Sinai School of Medicine, New York, NY 10029 USA. michael.farkouh@mssm.edu
Bansilal
Sameer
S
Fuster
Valentin
V
D015906:Angioplasty, Balloon, Coronary; D023903:Coronary Restenosis / Q000209:etiology*; D016503:Drug Delivery Systems; D006801:Humans; D009203:Myocardial Infarction / Q000209:etiology; D018570:Risk Assessment; D015607:Stents / Q000009:adverse effects*